Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: A randomised phase II study

A. Roy, D. Cunningham, R. Hawkins, H. Sörbye, A. Adenis, J. R. Barcelo, G. Lopez-Vivanco, G. Adler, J. L. Canon, F. Lofts, C. Castanon, E. Fonseca, O. Rixe, J. Aparicio, J. Cassinello, M. Nicolson, M. Mousseau, A. Schalhorn, L. D'Hondt, J. KergerD. K. Hossfeld, C. Garcia Giron, R. Rodriguez, P. Schoffski, J. L. Misset

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: A randomised phase II study'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science

    Biochemistry, Genetics and Molecular Biology